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The polyketide backbone of thiolactomycin is
assembled by an unusual iterative polyketide
synthase†
Marie E. Yurkovich,a Robert Jenkins,b Yuhui Sun,c Manuela Tosin*b and
Peter F. Leadlay*a
Following the in vivo investigation of thiotetronate assembly in
Lentzea sp. and in S. thiolactonus NRRL 15439 (Havemann et al.,
Chem. Commun., 2017, DOI: 10.1039/c6cc09933e), the minimal set
of genes required for thiolactomycin production was determined
through heterologous expression and the mechanism for polyketide
assembly was established in vitro through incubation of recombinant
TlmB with its substrates in the presence of either nonhydrolysable or
hydrolysable chemical probes. The results presented here constitute
unequivocal evidence of enzymatic processing by an unusual iterative
polyketide synthase.
In 2014, the World Health Organisation (WHO) declared anti-
microbial resistance a global health crisis, with a ‘post-
antibiotic era’ looming unless critical measures are taken.2
While rigorous changes in policy are required, there is also
an urgent need for eﬀective new antibiotics, and in particular,
for compounds that act on biological targets that are under-
exploited, highly conserved, essential for survival, and unique
to bacteria.3 Thiolactomycin (TLM, 1, Fig. 1C), a thiotetronate
antibiotic first discovered in 1982 from a soil Nocardia strain
(ATCC 31319,4 since re-named Lentzea sp.) reversibly inhibits
the b-ketoacyl-acyl carrier protein synthase (KAS) enzymes
of type II (dissociated) fatty acid synthase (FAS), an essential
metabolic pathway for bacterial cell viability.5 By binding
preferentially to the acyl–enzyme intermediate of the KAS
enzymes,6 TLM and other thiotetronates, such as Tu¨ 3010,7
confer broad antimicrobial activity against both Gram-positive
and Gram-negative bacteria and in murine models of infection.8
Additionally, thiotetronates show promise as a Mycobacterium
tuberculosis therapeutic9 as well as anti-malarial and anti-
trypanosomal activity through the inhibition of apicoplast type II
FAS.10 The broad spectrum antimicrobial activity displayed by
TLM, its effectiveness in murine models of infection, and its
favourable physical properties, have all established a rationale
for the development of TLM derivatives. To date, the more
ramified thiotetronate, Tu¨ 3010, has been reported to be 15-fold
more effective as an antibacterial in vivo, and various recent
synthetic modifications to the TLM C3- and C5-methyl groups
have led to increased activity against Plasmodium falciparum,
Francisella tularensis, methicillin-sensitive Staphyloccus aureus
(MSSA), and methicillin-resistant Staphyloccus aureus (MRSA).8b,11
The C5-chiral centre of thiotetronates highly complicates ana-
logue synthesis,12 making this class of natural products an
attractive target for genetic engineering. Early experiments with
Fig. 1 (A) Organisation of the proposed tlm cluster in Lentzea sp. and the
limits of the fragment cloned into pTLM. (B) LC-MS analysis of the selective
ion trace of thiolactomycin ([M + H]+ = 211.1 m/z) within WT and
recombinant heterologous strains. The asterisk means not detected. (C)
Confirmation of TLM production by MS-MS analysis.14
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isotopically-labelled precursors indicated that this class of
molecules were likely of polyketide origin.13 While the genetic
cluster was not initially identified, it was predicted that 1 would
be possibly assembled by a multimodular type I polyketide
synthase (PKS) as various levels of b-keto reduction would be
expected within the TLM polyketide scaffold. In 2015 the bio-
synthetic gene clusters for TLM (tlm) and Tu¨ 3010 (tue, stu, ssu)
were identified by comparative genetic analysis by our group14
and others.15 In silico analysis of the predicted tlm biosynthetic
gene cluster within the TLM producing strain Lentzea sp. revealed
only four open reading frames (ORFs): a gene encoding a copy of
the known TLM intracellular target KASI/II enzyme, tlmF; a gene
encoding an unexpected cytochrome P450, tlmD1, which we have
shown to be essential for TLM biosynthesis through in-frame
genetic mutation;14 tlmA, encoding a PKS-protein housing a KSQ
domain,16 and an acyl carrier protein (ACP) domain, therefore
likely acting as the initiation module; and tlmB, encoding a novel
multienzyme containing a single PKS extension module juxta-
posed at its C-terminus with several NRPS domains. Bioinformatic
analysis of this peculiar biosynthetic cluster led to the prediction
that the TLM tetraketide backbone would be assembled by the
ORFs tlmA and tlmB. TlmA was proposed to catalyse the attach-
ment of a malonyl group to the ACP and its subsequent decarbox-
ylation providing the acetate starter unit for TLM, likely borrowing
its required acyltransferase (AT) domain from the malonyl-
CoA:ACP acyl-transferase of fatty acid biosynthesis (MCAT), as
presented earlier in actinorhodin17 and FK228 biosyntheses.18
The predicted domain order within TlmB from the N-terminus
is ketosynthase (KS), acyltransferase (AT), dehydratase (DH),
ketoreductase (KR), acyl-carrier protein (ACP) domains, followed
by the NRPS domains: cyclisation (Cy), adenylation (A) and
peptidyl carrier protein (PCP). Therefore TlmB was envisaged
to act as an iterative type I PKS by recruiting three successive
propionate units and catalyzing three cycles of chain elongation.
In-frame gene mutation and complementation studies on tlmA
within the ATCC 31319 tlm cluster have revealed that tlmA is
essential for thiotetronate biosynthesis, strengthening our
proposed mechanism for thiotetronate polyketide assembly unex-
pectedly involving an iterative, rather than modular, system.14 An
encouraging precedent for such an iterative assembly-line is
the recently-uncovered PKS for the 14-macrocyclic polyketide
galbonolide.19 Validation of this mechanism requires isolation
and identification of the intermediate species. While this has
historically been a significant obstacle due to the covalent
attachment of all intermediates to polyketide synthase multi-
enzymes throughout chain assembly, a recently developed
chemical strategy has provided a useful way to sample and
identify PKS intermediates from both modular20 and iterative
systems.21 This strategy employs nonhydrolysable synthetic
mimics of the natural PKS extender units recruited for poly-
ketide formation. These small molecules act as competitive
substrates for the natural ACP-bound extender units, carrying
out decarboxylative condensation with the KS-tethered poly-
ketide: by decoying and removing the growing chain from the
PKS, the product from each round of chain extension can be
isolated and analysed. As reported by Havemann et al. in the
accompanying paper,1 in vivo feeding of nonhydrolysable syn-
thetic mimics to the TLM-producing strain Lentzea sp. resulted
in the capture and identification of putative thiolactomycin
polyketide intermediates1 including di-, tri- and tetraketide
species with the expected states of b-keto-reduction.1 However,
this work alone cannot conclusively demonstrate that only
TlmA and TlmB are sufficient for polyketide assembly. To do
this, the minimal set of genes required for TLM production was
first determined through heterologous expression of the gene
cluster in several heterologous Streptomyces hosts, and then the
mechanism for TLM polyketide assembly was enzymatically
reconstituted in vitro. The tlm cluster was cloned and trans-
planted into two genetically well-defined Streptomyces hetero-
logous host strains. The 13.7 kbp tlm cluster was PCR amplified
as a fragment containing terminal regions identical to the
NdeI- and EcoRI-digested ends of pIB139. This fragment was
then inserted into digested pIB139 through Gibson assembly,
transformed into Escherichia coli DH10B, and apramycin-
resistant pTLM containing colonies were confirmed through
PCR analysis and Sanger sequencing. pTLM (Fig. 1S, ESI†) was
introduced into the Streptomyces coelicolorM1154 and Streptomyces
lividans TK24 genomes by conjugation through the triply
methylation-deficient E. coli strain ET12567/pUZ8002. The
resulting transformed strains M1154::pTlm and TK24::pTlm
were cultured and the extracts analysed by LCMS. As shown
in Fig. 1, the recombinant strains gained the ability to produce
TLM at comparable/higher levels than those found in
Lentzea sp. Having independently identified a tlm cluster within
Salinispora pacifica CNS863, Tang et al. have also been success-
ful in demonstrating heterologous production of TLM in the
recombinant host M1152/pMXT13.15 TLM production in het-
erologous Streptomyces hosts has confirmed that only TlmA and
TlmB are required for assembly of the thiolactomycin poly-
ketide chain, and that the sulfur insertion machinery is borrowed
from primary metabolism.
To attempt the reconstitution of polyketide chain assembly
in vitro, we first undertook recombinant expression of the giant
PKS-NRPS multienzyme, TlmB. The N-terminally His6-tagged
316.8 kDa recombinant protein was expressed in E. coli BL21(DE3)
and purified by selective ammonium sulfate precipitation (Fig. 2A).
Matrix-assisted laser desorption/ionisation (MALDI) mass finger-
printing of recombinant TlmB, following tryptic digest, was used
to confirm the identity of the expressed protein (Fig. 2S, ESI†). To
ensure that the ACP domain of TlmB was in the active holo- form
through addition of a 40-phosphopantetheine (40PP) arm, the
broad-specificity 40PP transferase Sfp from B. subtilis22 was
co-expressed with recombinant TlmB. MALDI-TOF analysis to
determine whether co-expression had been successful was
inconclusive (Fig. 3S, ESI†), so CoASH and heterologously
purified Sfp were included in TlmB enzymatic assays to ensure
complete in vitro conversion of apo-ACP to holo. Based on the
assumption that TlmA is the initiating enzyme providing an
acetate starter unit for TlmB via malonate decarboxylation, we
replaced TlmA in these assays with acetyl-CoA (2). To reconsti-
tute thiolactomycin polyketide assembly and probe the proposed
iterative mechanism of TlmB, the same chain termination
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probes utilised by Havemann and co-workers1 in vivo were
employed in vitro. Prior to incubation with recombinant TlmB,
the malonate and fluoromalonate esters 4–5 were hydrolysed to the
corresponding carboxylates 6–7 through incubation with pig liver
esterase (PLE)20a (Fig. 2B). Purified TlmB, co-expressed with Sfp,
was incubated with each probe in the presence of assay substrates
acetyl-CoA (2) and (2RS)-methylmalonyl-CoA (3), as well as DTT and
NADPH. The enzyme assay mixtures were quenched and extracted
with ethyl acetate. High-resolution mass-spectrometry (HRMS)
analyses of the organic extracts showed the presence of putative
enoyl-diketide intermediates from both malonyl- and fluoroma-
lonyl terminator assays (8–9, Fig. 2B and Fig. 4S, 10S, ESI†),
indicating that acetyl-CoA could indeed replace TlmA to initiate
chain extension through loading of acetyl groups onto recombi-
nant TlmB. Additionally, for each terminator species, b-keto and
b-hydroxy diketide intermediates were also detected (Table 4S
and Fig. 4S, 10S, ESI†), revealing all the reductive enzyme-
catalysed steps employed during the first round of chain exten-
sion. Furthermore, dienoyl triketide intermediates from the
second round of TlmB chain extension (10–11) were also
detected, albeit in minor amounts, from both malonyl- and
fluoromalonyl terminator assays, as well as triketide b-keto and
b-hydroxy species (Fig. 6S and 12S, ESI†). Finally, from the third
and final round of TlmB chain extension, we were able to detect
off-loaded dienoyl tetraketides (e.g. 12) in organic extracts
(Fig. 1B, C and Fig. 8S, ESI†). None of these putative intermedi-
ates, each characterised by HR-MSn analyses, were found in
controls containing boiled TlmB; and the intermediates were
virtually identical to those identified from in vivo feeding
studies,1 supporting substrate processing by TlmB as an iterative
synthase. To further confirm substrate processing by TlmB to
dienoyl tetraketides, the hydrolysable N-acetylcysteamine trike-
tide 14 was synthesised according to Scheme 1S (ESI†) and
utilised to prime TlmB. Addition of chain termination probes
6–7 to the newly primed TlmB in the presence of the natural
extender unit 3 led to the formation of dienoyl tetraketides 12–13
(Fig. 2D and Fig. 9S, 13S, ESI†). No further elaborated polyketide
species (e.g. reduced tetraketides) were detected. These results
taken together constitute unequivocal evidence of polyketide chain
building and processing by an iterative enzyme in thiotetronate bio-
assembly. The discovery that the thiotetronate polyketide backbone
is assembled by an iterative PKS is particularly interesting given
that a different level of b-keto reduction is required during the final
cycle. Further, in the case of the more elaborate Tu¨ 3010
and thiotetronomycin structures, both methylmalonyl-CoA and
ethylmalonyl-CoA extension units are selected and activated by a
single AT domain. The successful reconstitution of this system
in vitro makes this recombinant enzyme an attractive system for
further structural studies. High resolution structural investigation
of TlmB could provide insights into the poorly-understood23 factors
that control reduction within iterative PKSs, and pave the way to
future engineering of unnatural thiotetronates.
Complete in vitro reconstitution of the PKS enzymology
within TLM biosynthesis has confirmed an unexpectedly itera-
tive method of assembly. This work has now paved the way for
the investigation of post-PKS mechanisms leading to sulfur-
insertion and thiolactone formation.
We gratefully acknowledge support from the Herchel Smith
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R. J.); and Dr Cleidiane Zampronio (School of Life Sciences,
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Fig. 2 (A) SDS-PAGE analysis of recombinant TlmB. (B) Chain termination probes 6 and 7, generated from PLE-catalysed hydrolysis of 4 and 5, compete
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of recombinant TlmB with the synthetic SNAc triketide 14 in the presence of probe 6 or 7 results in the formation of species 12 or 13 (ESI†).
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